These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36420161)

  • 41. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
    Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
    Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
    Advani D; Kumar P
    ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A review of computational drug repurposing.
    Park K
    Transl Clin Pharmacol; 2019 Jun; 27(2):59-63. PubMed ID: 32055582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
    Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
    Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
    Palomino JC; Martin A
    J Antimicrob Chemother; 2013 Feb; 68(2):275-83. PubMed ID: 23075693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-repurposing identified the combination of Trolox C and Cytisine for the treatment of type 2 diabetes.
    Jin L; Tu J; Jia J; An W; Tan H; Cui Q; Li Z
    J Transl Med; 2014 May; 12():153. PubMed ID: 24885253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation.
    Thatikonda S; Pooladanda V; Godugu C
    J Cell Physiol; 2020 Jun; 235(6):5270-5283. PubMed ID: 31846070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applying polypharmacology approach for drug repurposing for SARS-CoV2.
    Jamir E; Sarma H; Priyadarsinee L; Nagamani S; Kiewhuo K; Gaur AS; Rawal RK; Murugan NA; Subramanian V; Sastry GN
    J Chem Sci (Bangalore); 2022; 134(2):57. PubMed ID: 35498548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
    Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
    BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Comparison of Network-Based Methods for Drug Repurposing along with an Application to Human Complex Diseases.
    Fiscon G; Conte F; Farina L; Paci P
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent Advances in Drug Repurposing for Parkinson's Disease.
    Chen X; Gumina G; Virga KG
    Curr Med Chem; 2019; 26(28):5340-5362. PubMed ID: 30027839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing.
    Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H
    JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
    Chopra G; Samudrala R
    Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.
    Usha T; Middha SK; Kukanur AA; Shravani RV; Anupama MN; Harshitha N; Rahamath A; Kukanuri SA; Goyal AK
    Curr Protein Pept Sci; 2020 Sep; ():. PubMed ID: 32957901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.
    Li Y; Duche A; Sayer MR; Roosan D; Khalafalla FG; Ostrom RS; Totonchy J; Roosan MR
    BMC Genomics; 2021 Feb; 22(1):125. PubMed ID: 33602138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel computational approach for drug repurposing using systems biology.
    Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
    Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.